131 related articles for article (PubMed ID: 10731970)
41. Amifostine-mediated protection of normal bone marrow from cytotoxic chemotherapy.
Capizzi RL; Scheffler BJ; Schein PS
Cancer; 1993 Dec; 72(11 Suppl):3495-501. PubMed ID: 8242582
[TBL] [Abstract][Full Text] [Related]
42. [Individualized cancer treatment. Illustrated by acute lymphoblastic leukemia in children].
Schmiegelow K
Ugeskr Laeger; 2001 Feb; 163(8):1062-6. PubMed ID: 11242663
[TBL] [Abstract][Full Text] [Related]
43. [Cytoprotective effect of amifostine in children during induction therapy according to BFM-83: report on cases].
Nowak K; Bolanowski W; Zalewska-Szewczyk B; Stolarska M; Bodalski J
Wiad Lek; 1998; 51 Suppl 4():220-6. PubMed ID: 10731972
[TBL] [Abstract][Full Text] [Related]
44. Toxicity prevention with amifostine in pediatric osteosarcoma patients treated with cisplatin and doxorubicin.
Gallegos-Castorena S; Martínez-Avalos A; Mohar-Betancourt A; Guerrero-Avendaño G; Zapata-Tarrés M; Medina-Sansón A
Pediatr Hematol Oncol; 2007 Sep; 24(6):403-8. PubMed ID: 17710657
[TBL] [Abstract][Full Text] [Related]
45. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
[TBL] [Abstract][Full Text] [Related]
46. [Convulsions during treatment of acute lymphoblastic leukemia in children].
Mainero G; Barisone E; Boffi P; Farinasso L; Landolfi C; Dalponte S; Sicca E; Papalla F; Miniero R; Madon E
Minerva Pediatr; 2000 Apr; 52(4):205-14. PubMed ID: 11995204
[TBL] [Abstract][Full Text] [Related]
47. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
Uderzo C; Dini G; Locatelli F; Miniero R; Tamaro P
Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324
[TBL] [Abstract][Full Text] [Related]
48. [Herpes zoster-associated morbidity in children undergoing chemotherapy for acute lymphoblastic leukaemia].
Sørensen GV; Helgestad J; Rosthøj S
Ugeskr Laeger; 2009 Nov; 171(46):3350-4. PubMed ID: 19925740
[TBL] [Abstract][Full Text] [Related]
49. Administration of Ethyol (amifostine) to a child with medulloblastoma to ameliorate hematological toxicity of high dose carboplatin.
Borsi JD; Csaki C; Ferencz T; Oster W
Anticancer Drugs; 1996 Jan; 7(1):121-6. PubMed ID: 8742109
[TBL] [Abstract][Full Text] [Related]
50. The need for cytoprotection.
Bukowski RM
Eur J Cancer; 1996; 32A Suppl 4():S2-4. PubMed ID: 8976815
[TBL] [Abstract][Full Text] [Related]
51. Radioprotectants: pharmacology and clinical applications of amifostine.
Dorr RT
Semin Radiat Oncol; 1998 Oct; 8(4 Suppl 1):10-3. PubMed ID: 9794995
[TBL] [Abstract][Full Text] [Related]
52. The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine (Ethyol).
Capizzi RL
Eur J Cancer; 1996; 32A Suppl 4():S5-16. PubMed ID: 8976816
[TBL] [Abstract][Full Text] [Related]
53. Amifostine (Ethyol): dosing, administration and patient management guidelines.
Bukowski RM
Eur J Cancer; 1996; 32A Suppl 4():S46-9. PubMed ID: 8976823
[TBL] [Abstract][Full Text] [Related]
54. Bone marrow purging by photodynamic treatment in children with acute leukemia: cytoprotective action of amifostine.
Danilatou V; Lydaki E; Dimitriou H; Papazoglou T; Kalmanti M
Leuk Res; 2000 May; 24(5):427-35. PubMed ID: 10785265
[TBL] [Abstract][Full Text] [Related]
55. Clinical nanomedicine: a solution to the chemotherapy conundrum in pediatric leukemia therapy.
Krishnan V; Rajasekaran AK
Clin Pharmacol Ther; 2014 Feb; 95(2):168-78. PubMed ID: 24013811
[TBL] [Abstract][Full Text] [Related]
56. Amifostine: potential for clinically useful cytoprotection.
Budd GT; Lorenzi V; Ganapathi R; Adelstein D; Pelley R; Olencki T; McLain D; Bukowski RM
Support Care Cancer; 1994 Nov; 2(6):380-4. PubMed ID: 7858931
[TBL] [Abstract][Full Text] [Related]
57. Commentary: the pharmacological antioxidant amifostine -- implications of recent research for integrative cancer care.
Block KI; Gyllenhaal C
Integr Cancer Ther; 2005 Dec; 4(4):329-51. PubMed ID: 16465691
[TBL] [Abstract][Full Text] [Related]
58. Use of amifostine, a novel cytoprotective, in alpha-amanitin poisoning.
Wills BK; Haller NA; Peter D; White LJ
Clin Toxicol (Phila); 2005; 43(4):261-7. PubMed ID: 16035202
[TBL] [Abstract][Full Text] [Related]
59. Aggressive chemotherapy of ALL in elderly patients.
Hoelzer D
Hematol Oncol; 1993; 11 Suppl 1():12-4. PubMed ID: 8486336
[No Abstract] [Full Text] [Related]
60. [Acute leukemia: oral manifestations and treatment].
Shubich I
Pract Odontol; 1990 Sep; 11(9):21-2, 24, 26-7. PubMed ID: 2151940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]